Clinical Study Results
Research Sponsor: AstraZeneca AB
Drug Studied: MEDI4736 and tremelimumab
Study Title: A study to find out how MEDI4736 given alone or
with tremelimumab works in participants with cancer
of the bladder or urinary system that has spread
and cannot be removed by surgery
Thank you!
Thank you to the participants for taking part in the clinical study for the study drugs
MEDI4736 and tremelimumab.
All of the participants helped researchers learn more about MEDI4736 to help people
with cancer of the bladder or urinary system that has spread and cannot be removed by
surgery.
AstraZeneca AB sponsored this study and believes it is important to share the results
of the study with you and the public. An independent non-profit organization called
CISCRP helped prepare this summary of the study results for you. We hope it helps you
understand and feel proud of your important role in medical research.
If you participated in the study and have questions about the results, please speak with
the study doctor or staff at your study site.
1